All In MedTech

Device Trial Radar · NCT01033357

Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access

A Long Term Safety Study of the Vascular Wrap(TM) Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan® Graft in the Upper Extremity for Hemodialysis Vascular Access

Last checked: Nov 19, 2026Latest source record: Feb 11, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 222 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

222

Actual

Start

Mar 2008

Primary completion

Mar 2010

Study completion Oct 2010

Sponsor

Lead sponsor
Angiotech PharmaceuticalsNot on our public-company list
Sponsor type
Industry
First posted
Dec 16, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the long term use of the experimental Vascular Wrap(TM) Paclitaxel-Eluting Mesh is safe in the treatment of subjects needing hemodialysis access (via an expanded polytetrafluoroethylene (ePTFE) graft).

Conditions

  • End Stage Renal Failure on Dialysis
  • Hyperplasia

Interventions

  • Graft, Vascular WrapDevice

    Lifespan® ePTFE Vascular Graft and Vascular Wrap Paclitaxel-Eluting Mesh (0.9 µg/mm2 paclitaxel)

  • Lifespan® ePTFE Vascular Graft OnlyDevice

    Vascular Graft only

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Nature and incidence of Adverse Events between treatment groups clinical difference in product-related adverse eventsTime frame: 4 years

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Ladenheim, Inc.

    Fresno, California

  • Centinela Hospital

    Inglewood, California

  • National Institute of Clinical Research

    Los Angeles, California

27 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.